An MDS-derived cell line and a series of its sublines serve as an in vitro model for the leukemic evolution of MDS

Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma

Peter W. Lewis, Manuel M. Müller, Matthew S. Koletsky et al. · Science · 2013 · 1.4K citations · Full text

Medicine, Genetics, Oncology +17

Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS

Jan Krönke, Emma C. Fink, Paul W. Hollenbach et al. · Nature · 2015 · 836 citations · Full text

Medicine, Molecular Biology, Oncology +8

EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas

Faizaan Mohammad, Simon Weissmann, Benjamin Leblanc et al. · Nature Medicine · 2017 · 530 citations

Medicine, Cancer Biology, Oncology +14

Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma

Rintaro Hashizume, Noemi Andor, Yuichiro Ihara et al. · Nature Medicine · 2014 · 485 citations · Full text

Medicine, Oncology, Pharmacology +16

Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome

Garrett W. Rhyasen, Lyndsey Bolanos, Jing Fang et al. · Cancer Cell · 2013 · 201 citations · Full text

Medicine, Molecular Medicine, Pharmacology +7